BioCentury
ARTICLE | Clinical News

EGEN-001: Phase II started

December 20, 2010 8:00 AM UTC

Egen said the Gynecologic Oncology Group (GOG) began an open-label Phase II trial in 56 patients to evaluate weekly intraperitoneal EGEN-001 in a 4-week cycle. ...